FDA: Avoid certain online drugs from Canada

The Food and Drug Administration has issued a consumer warning about buying prescription drugs online from certain web sites.

The U.S. Food and Drug Administration (FDA) is advising consumers not to purchase prescription drugs from websites that have orders filled by Mediplan Prescription Plus Pharmacy or Mediplan Global Health in Manitoba, Canada following reports of counterfeit versions of prescription drug products being sold by these companies to U.S. consumers. FDA is investigating these reports and is coordinating with international law enforcement authorities on this matter.

The FDA lists the following suspect drugs:

• LIPITOR - Cholesterol disorders


• CRESTOR - Cholesterol disorders


• ZETIA (US name) / EZETROL (Canadian name) - Cholesterol disorders


• DIOVAN - High blood pressure


• HYZAAR - High blood pressure


• ACTONEL - Osteoporosis in postmenopausal women


• NEXIUM - Gastroesophageal reflux disease (GERD)


• CELEBREX - Arthritis-related pain


• ARIMIDEX - Breast cancer


• PROPECIA - Male-pattern baldness

Web sites under investigation include:

• www.RxNorth.com;


• www.Canadiandrugstore.com;


• www.Rxbyfax.com;


• www.Northcountryrx.com;


• www.Canada-pharmacy.com;


• www.My-canada-pharmacy.com;


• www.NLRX.com;


• www.Canampharmacy.com;


• www.Canada-Meds-For-Less.net;


• www.Canadian-safe.com